semaglutide method of action Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? Semaglutide as a GLP-1 Agonist:

Semaglutide is used for chronic weight management, obesity, and type-2 diabetes

Certain individuals may not be eligible for semaglutide, such as those with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

Eli Lilly and Company ZEPBOUND (tirzepatide) injection Prescribing Information FDA / DailyMed (2026) 5

Carnitine insufficiency, represented by increased AC/FC, in HF, especially in HFpEF, have also been previously reported by Yoshihisa et al

Increased cell death may be induced by an increased oxidative stress burden or a modification of the redox balance of gastric epithelial cells following Gln depletion 15,47